Prevalence of Treated Epilepsy in Korea Based on National Health Insurance Data

Prevalence of Treated Epilepsy in Korea Based on National Health Insurance Data
复制标题

DOI:
10.3346/jkms.2012.27.3.285
复制
发表时间:
2012-03-01
影响因子:
4.5
通讯作者:
Kim, Sejin
Kim, Sejin
中科院分区:
医学4区
文献类型:
--
作者:
Lee, Seo-Young;Jung, Ki-Young;Kim, Sejin

文献摘要

被引文献

相似文献

韩国的国民健康保障体系覆盖了全体国民和所有医疗设施。我们的目的是估计癫痫患病率,抗惊厥药的使用模式和成本。我们根据2007年韩国国民健康保险数据库中提示癫痫发作或癫痫的诊断代码,通过抗惊厥药物的处方确定了流行的癫痫患者。提取人口统计、居住区域、反映经济状况的医疗保障服务种类、抗惊厥药物、费用等信息。接受治疗的癫痫患者的总体患病率为2.41/ 1000,男性高于女性。按年龄划分的患病率最低的是30多岁和40多岁。癫痫在接受医疗救助的低收入人群中更为普遍。地区患病率最高的是济州岛,最低的是蔚山市。在年轻年龄组中,新型抗惊厥药的使用频率高于旧的抗惊厥药。每年治疗癫痫或癫痫发作的总费用占总医疗开支的0.46%,占总保健开支的0.27%。这是韩国首次发表的全国范围的癫痫流行病学报告。韩国的癫痫发病率与发达国家相当。经济状况和地理位置影响癫痫的患病率。
The Korean national health security system covers the entire population and all medical facilities. We aimed to estimate epilepsy prevalence, anticonvulsant utilization pattern and the cost. We identified prevalent epilepsy patients by the prescription of anticonvulsants under the diagnostic codes suggesting seizure or epilepsy from 2007 Korean National Health Insurance databases. The information of demography, residential area, the kind of medical security service reflecting economic status, anticonvulsants, and the costs was extracted. The overall prevalence of treated epilepsy patients was 2.41/1,000, and higher for men than women. The age-specific prevalence was the lowest in those in their thirties and forties. Epilepsy was more prevalent among lower-income individuals receiving medical aid. The regional prevalence was the highest in Jeju Island and lowest in Ulsan city. New anticonvulsants were more frequently used than old anticonvulsants in the younger age group. The total annual cost of epilepsy or seizure reached 0.46% of total medical expenditure and 0.27% of total expenditure on health. This is the first nationwide epidemiological report issued on epilepsy in Korea. Epilepsy prevalence in Korea is comparable to those in developed countries. Economic status and geography affect the prevalence of epilepsy.